🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the safety, tolerability and efficacy of molnup...
Status
Terminated
Location
Kaiser Foundation Hospital - South Bay ( Site 1832)
Start Date
2020-10-19
Trial ID
NCT04575584
Treatments Being Tested
The AGILE platform master protocol allows incorporation of a range of ident...
Status
Recruiting
Location
Desmond Tutu Health Foundation
Start Date
2020-07-03
Trial ID
NCT04746183
The purpose of the study is to assess if the study medication (molnupiravir...
Status
Completed
Location
Cahaba Research, Inc. ( Site 2523)
Start Date
2021-08-11
Trial ID
NCT04939428
Treatments Being Tested
This is a prospective, placebo controlled, individually randomized controll...
Status
Terminated
Location
KU Leuven
Start Date
2021-06-15
Trial ID
NCT04730206
Treatments Being Tested
This study aims to evaluate the safety, tolerability and efficacy of molnup...
Status
Completed
Location
Phoenix Medical Group ( Site 1822)
Start Date
2020-10-19
Trial ID
NCT04575597
Treatments Being Tested
This is a phase 2a double-blind, randomized, placebo-controlled study to ev...
Status
Completed
Location
hVIVO Services ( Site 0001)
Start Date
2023-08-21
Trial ID
NCT05818124
Treatments Being Tested
This was a phase IIa, double-blind, placebo-controlled, randomized trial, d...
Status
Completed
Location
Valley Clinical Trials, Inc.
Start Date
2020-06-19
Trial ID
NCT04405570
Treatments Being Tested
This is a study of molnupiravir (MK-4482) in healthy participants who have ...
Status
Completed
Location
hVIVO Services ( Site 0001)
Start Date
2022-11-02
Trial ID
NCT05559905
Treatments Being Tested
This is a multi-centre, double-blind, phase 3 study to observe the effectiv...
Status
Completed
Location
Nelson Mandela Academic Clinical Research Unit (NeMACRU)
Start Date
2022-08-12
Trial ID
NCT05459532
Treatments Being Tested
This is a First In Human study designed to assess the safety, tolerability ...
Status
Completed
Location
Covance Leeds Clinical Research Unit
Start Date
2020-04-10
Trial ID
NCT04392219